Biomedical Engineering Reference
In-Depth Information
85. Buchholz, T.A.,
Factors predictive of outcome in patients with
breast cancer refractory to neoadjuvant chemotherapy.
et al.
Cancer J
7
,
413-420 (2001).
86. Dowsett, M.,
Prognostic value of Ki67 expression after short-term
presurgical endocrine therapy for primary breast cancer.
et al.
J Natl Cancer
, 167-170 (2007).
87. Ellis, M.J.,
Inst
99
Outcome prediction for estrogen receptor-positive
breast cancer based on postneoadjuvant endocrine therapy tumor
characteristics.
et al.
, 1380-1388 (2008).
88. Chia, Y.H., Ellis, M.J., and Ma, C.X. Neoadjuvant endocrine therapy in
primary breast cancer: indications and use as a research tool.
J Natl Cancer Inst
100
Br J
, 759-764 (2010).
89. Rastelli, F., and Crispino, S. Factors predictive of response to hormone
therapy in breast cancer.
Cancer
103
, 370-383 (2008).
90. Ring, A., and Dowsett, M. Mechanisms of tamoxifen resistance.
Tumori
94
Endocr
Relat Cancer
11
, 643-658 (2004).
91. Ottaviano, Y.L.,
Methylation of the estrogen receptor gene CpG
island marks loss of estrogen receptor expression in human breast
cancer cells.
et al.
, 2552-2555 (1994).
92. Yang, X., Yan, L., and Davidson, N.E. DNA methylation in breast cancer.
Endocr Relat Cancer
Cancer Res
54
8
, 115-127 (2001).
93. Lapidus, R.G.,
Methylation of estrogen and progesterone receptor
gene 5' CpG islands correlates with lack of estrogen and progesterone
receptor gene expression in breast tumors.
et al.
Clin Cancer Res
2
, 805-810
(1996).
94. Yang, X.,
Synergistic activation of functional estrogen receptor
(ER)-alpha by DNA methyltransferase and histone deacetylase
inhibition in human ER-alpha-negative breast cancer cells.
et al.
Cancer Res
, 7025-7029 (2001).
95. Gutierrez, M.C.,
61
Molecular changes in tamoxifen-resistant breast
cancer: relationship between estrogen receptor, HER-2, and p38
mitogen-activated protein kinase.
et al.
, 2469-2476 (2005).
96. Herynk, M.H., and Fuqua, S.A. Estrogen receptor mutations in human
disease.
J Clin Oncol
23
, 869-898 (2004).
97. Musgrove, E.A., and Sutherland, R.L. Biological determinants of
endocrine resistance in breast cancer.
Endocr Rev
25
Nat Rev Cancer
9
, 631-643
(2009).
98. Osborne, C.K., and Schiff, R. Mechanisms of endocrine resistance in
breast cancer.
Annu Rev Med
62
, 233-247 (2011).
